Results 21 to 30 of about 256,850 (180)

Gastropathy associated with lanthanum phosphate deposition that was endoscopically tracked for 3 years. A case report

BMC Gastroenterology, 2020
Background With the recent increased use of lanthanum carbonate, several cases of lanthanum phosphate deposition to gastric mucosa in dialysis patients have been reported.
Akiko Ohno, Jun Miyoshi, Hidesato Tanabe, Mitsunori Kusuhara, Masao Toki, Tomohiro Chiba, Hiroaki Shimoyamada, Junji Shibahara, Tadakazu Hisamatsu   +8 more
doaj   +1 more source

The Pharmacological Effect and Mechanism of Lanthanum Hydroxide on Vascular Calcification Caused by Chronic Renal Failure Hyperphosphatemia

Frontiers in Cell and Developmental Biology, 2021
ObjectiveThe present work aimed to explore the efficacy of lanthanum hydroxide in managing the vascular calcification induced by hyperphosphate in chronic renal failure (CRF) as well as the underlying mechanism.MethodsRats were randomly allocated to five
Lulu Zhao, Shengnan Wang, Hong Liu, Xiaoli Du, Ren Bu, Bing Li, Ruilan Han, Jie Gao, Yang Liu, Jian Hao, Jianrong Zhao, Yan Meng, Gang Li   +12 more
doaj   +1 more source

XAFS spectrum of Lanthanum carbonate, anhydrous

, 2021
This dataset consists of X-ray absorption fine structure (XAFS) spectra at La K-edge of Lanthanum carbonate, anhydrous measured at SPring-8 BL14B2, and is a part of XAFS database (MDR XAFS DB, https://doi.org/10.48505/nims.1447) as a collection of ...
Industrial Application and Partnership Division
core   +2 more sources

Novel case of laparoscopically resected gastric adenocarcinoma concurrent with lanthanum deposition

Clinical Case Reports, 2022
A 73‐year‐old man taking lanthanum carbonate for hemodialysis showed progressing gastric mucosal changes with lanthanum deposition. Regular examination revealed concurrent gastric carcinoma.
Kosuke Hirose, Shunichi Saito, Yumi Oshiro, Kazuhito Minami, Koji Ikegami, Koichi Kurahara, Takuya Honbo, Noriaki Sadanaga, Hiroshi Matsuura   +8 more
doaj   +1 more source

Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients

BMC Nephrology, 2013
Background This short-term study assessed the efficacy and safety of lanthanum carbonate in the treatment of hyperphosphatemia in dialysis patients; here, we report a prespecified subgroup analysis of patients undergoing peritoneal dialysis.
Hutchison Alastair J, Gill Maggie, Copley J Brian, Poole Lynne, Wilson Rosamund J   +4 more
doaj   +1 more source

Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden

, 2008
BACKGROUND: Despite recognized risks associated with hyperphosphataemia in patients with chronic kidney disease (CKD) Stage 5 on dialysis, the achievement of target levels of serum phosphate is poor. It is likely that this is partly due to poor adherence
LAVILLE M, HUTCHISON AJ, ALBERTAZZI, Alberto, SPD LANTHANUM STUDY GROUP   +3 more
core   +2 more sources

The effects of lanthanum carbonate and calcium carbonate on bone abnormalities in patients with end-stage renal disease

, 2005
Background: Renal osteodystrophy is a common complication of end-stage renal disease (ESRD) and is a major cause of morbidity in patients with ESRD. High serum levels of phosphorus, calcium and parathyroid hormone are associated with the development of ...
Freemont, A. J.; id_orcid, Hoyland, J. A., Denton, J.   +2 more
core   +8 more sources

Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China

BMC Nephrology, 2013
Background Serum phosphorus control is critical for chronic kidney disease (CKD) 5D patients. Currently, clinical profile for an oral phosphorus binder in the mainland Chinese population is not available.
Xu Jing, Zhang Yi-Xiang, Yu Xue-Qing, Liu Zhi-Hong, Wang Li-Ning, Chen Jiang-Hua, Fan Ya-Ping, Ni Zhao-Hui, Wang Mei, Yuan Fa-Huan, Ding Guo-Hua, Chen Xiang-Mei, Zhang Ai-Ping, Mei Chang-Lin   +13 more
doaj   +1 more source

Localization of lanthanum in bone of chronic renal failure rats after oral dosing with lanthanum carbonate

, 2005
Background. Lanthanum carbonate has been shown to be a safe, effective phosphate-binding agent. We have shown that an impaired mineralization in chronic renal failure rats treated with high doses of lanthanum carbonate develops secondary to phosphate ...
Behets, Geert J., Bervoets, An R., D'Haese, Patrick C., Denton, John, Cox, Alan G., Salomé, Murielle, De Broe, Marc E., Verberckmoes, Steven C., Oste, Line   +8 more
core   +5 more sources

Measurement of serum lanthanum in patients treated with lanthanum carbonate by inductively coupled plasma-mass spectrometry

, 2011
Background Lanthanum carbonate is used as a phosphate binder in patients with stage V chronic kidney disease (CKD). While well tolerated in clinical trials, with no toxicity reported as regards bone and liver metabolism, and cognitive function, concerns ...
K B Raja, R J Flanagan, Raja, K B, Flanagan, R J, Sharpe, C, C Sharpe, S A Handley, Handley, S A   +7 more
core   +2 more sources